NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland

FT. MYERS, FL–(Marketwired – October 24, 2017) – NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services in the United States, announced today that it has opened its first international laboratory facility in Rolle, Switzerland, in the Canton of Vaud, just outside of Geneva as a separate subsidiary, NeoGenomics Europe, S.A. This expansion brings NeoGenomics’ unique